Emory University will integrate a label-free Corning Epic System into its drug discovery programme at the Emory Chemical Biology Discovery Center (ECBDC).
The Corning Epic System is a high-throughput label-free screening system.
It can perform biochemical and cell-based assays without radioactive or fluorescent dyes, which can interfere with biochemical interactions.
It uses optical biosensors to measure a range of biological responses that are undetectable with conventional methods.
This technology will let ECBDC develop chemical tools for biological research and drive the discovery of new drug compounds.
ECBDC is part of the Molecular Libraries Screening Centers Network (MLSCN), which is funded by the National Institutes of Health (NIH).
The MLSCN consists of 10 screening centres focused on discovering new chemical probes via a diverse set of screening platform technologies.
It also serves Emory investigators and off-campus collaborators for their small molecule lead discovery needs.
Ron Verkleeren, business director of Corning Epic System, said: 'Epic's ability to non-invasively monitor the real-time responses of small molecular compounds in living cells will provide Emory with valuable insights that could streamline their search for new drugs.'
